Jessel S - Search Results

1

KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.

Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, McGeary MK, Song E, Blenman KRM, Micevic G, Jessel S, Zhang Y, Yin M, Booth CJ, Jilaveanu LB, Damsky W, Sznol M, Kluger HM, Iwasaki A, Bosenberg MW, Yan Q. Zhang SM, et al. Among authors: jessel s. Nature. 2021 Oct;598(7882):682-687. doi: 10.1038/s41586-021-03994-2. Epub 2021 Oct 20. Nature. 2021. PMID: 34671158 Free PMC article.

2

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells.

Lucca LE, Axisa PP, Lu B, Harnett B, Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Lucca LE, et al. Among authors: jessel s. J Exp Med. 2021 Apr 5;218(4):e20200921. doi: 10.1084/jem.20200921. J Exp Med. 2021. PMID: 33651881 Free PMC article.

3

Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report.

Jessel S, Austin M, Kluger HM. Jessel S, et al. Clin Oncol Case Rep. 2021 Jan;4(1):156. Epub 2021 Jan 15. Clin Oncol Case Rep. 2021. PMID: 33763663 Free PMC article.

4

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.

Tran TT, Rane CK, Zito CR, Weiss SA, Jessel S, Lucca L, Lu BY, Oria VO, Adeniran A, Chiang VL, Omay SB, Hafler DA, Kluger HM, Jilaveanu LB. Tran TT, et al. Among authors: jessel s. Cancers (Basel). 2021 Mar 2;13(5):1049. doi: 10.3390/cancers13051049. Cancers (Basel). 2021. PMID: 33801444 Free PMC article.

5

A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.

Weiss SA, Djureinovic D, Jessel S, Krykbaeva I, Zhang L, Jilaveanu L, Ralabate A, Johnson B, Levit NS, Anderson G, Zelterman D, Wei W, Mahajan A, Trifan O, Bosenberg M, Kaech SM, Perry CJ, Damsky W, Gettinger S, Sznol M, Hurwitz M, Kluger HM. Weiss SA, et al. Among authors: jessel s. Clin Cancer Res. 2021 Sep 1;27(17):4757-4767. doi: 10.1158/1078-0432.CCR-21-0903. Epub 2021 Jun 17. Clin Cancer Res. 2021. PMID: 34140403 Free PMC article. Clinical Trial.

6

Inhibition of renalase drives tumour rejection by promoting T cell activation.

Guo X, Jessel S, Qu R, Kluger Y, Chen TM, Hollander L, Safirstein R, Nelson B, Cha C, Bosenberg M, Jilaveanu LB, Rimm D, Rothlin CV, Kluger HM, Desir GV. Guo X, et al. Among authors: jessel s. Eur J Cancer. 2022 Apr;165:81-96. doi: 10.1016/j.ejca.2022.01.002. Epub 2022 Feb 24. Eur J Cancer. 2022. PMID: 35219026 Free PMC article.

7

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.

Jessel S, Weiss SA, Austin M, Mahajan A, Etts K, Zhang L, Aizenbud L, Perdigoto AL, Hurwitz M, Sznol M, Herold KC, Kluger HM. Jessel S, et al. Front Oncol. 2022 Mar 8;12:836859. doi: 10.3389/fonc.2022.836859. eCollection 2022. Front Oncol. 2022. PMID: 35350573 Free PMC article.

8

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.

Vathiotis IA, Salichos L, Martinez-Morilla S, Gavrielatou N, Aung TN, Shafi S, Wong PF, Jessel S, Kluger HM, Syrigos KN, Warren S, Gerstein M, Rimm DL. Vathiotis IA, et al. Among authors: jessel s. NPJ Precis Oncol. 2022 Dec 15;6(1):92. doi: 10.1038/s41698-022-00330-3. NPJ Precis Oncol. 2022. PMID: 36522538 Free PMC article.

9

Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma.

Dizman N, Austin M, Considine B, Jessel S, Schoenfeld D, Merl MY, Hurwitz M, Sznol M, Kluger H. Dizman N, et al. Among authors: jessel s. Clin Genitourin Cancer. 2023 Apr;21(2):221-229. doi: 10.1016/j.clgc.2023.01.002. Epub 2023 Jan 12. Clin Genitourin Cancer. 2023. PMID: 36681606

10

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy.

Martinez-Morilla S, Moutafi M, Fernandez AI, Jessel S, Divakar P, Wong PF, Garcia-Milian R, Schalper KA, Kluger HM, Rimm DL. Martinez-Morilla S, et al. Among authors: jessel s. Oncoimmunology. 2023 Sep 27;12(1):2260618. doi: 10.1080/2162402X.2023.2260618. eCollection 2023. Oncoimmunology. 2023. PMID: 37781235 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters